Cryptococcosis in Denmark: An analysis of 28 cases in 1988-1993

Scandinavian Journal of Infectious Diseases

Volumn 29, Issue 1, 1997, Pages 51-55

  Knudsen, Jenny Dahl ^a   Jensen, Lise ^b   Sørensen, Thomas Lund ^c   Jensen, Trine ^a   Kjersem, Helge ^b   Stenderup, Jørgen ^c   Pedersen, Court ^a  

^a STATENS SERUM INSTITUT   (Denmark)

^b Rigshospitalet   (Denmark)

^c HVIDOVRE HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CLINICAL ARTICLE; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; DENMARK; FEVER; FUNGEMIA; HEADACHE; HUMAN; MEDICAL RECORD; MENINGITIS; SEROTYPE;

EID: 0030908030     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365549709008664     Document Type: Article

References (18)

1. Dismukes WE. Management of cryptococcosis. Clin Infect Dis 17 SuppI 2: S507-512, 1993.
2. Mitchell TG, Perfect JR. Cryptococcosis in the era of AIDS-100 years after the discovery of the Cryptococcus neoformans. Clin Microbiol Rev 8: 515-548, 1995.
3. Powderly WG. Cryptococcal meningitis and AIDS. Clin Infect Dis 17: 837-842, 1993.
4. Knight FR, Mackenzie DW, Evans BG, Porter K, Barrnett NJ, White GC. Increasing incidence of cryptococcosis in the United Kingdom. J Infect 27: 185-191, 1993.
5. Paya CV. Fungal infections in solid-organ transplantation. Clin Infect Dis 16: 677-688, 1993.
6. Crowe SM, Carlin JB, Stewart KI, Lucas CR, Hoy JF. Predictive value of CD4 lymphocyte numbers for the development of opportunistic infections and malignancies in HIV-infected persons. J Acquired Immune Defic Syndrom 4: 770-776, 1991.
7. Masur H, Ognibene FP, Yarchoan R, Shelhamer JH, Baird BF, Travis W, SufTredini AF, Deyton L, Kovacs JA, Falloon J, Davey R, Pois M, Metcalf J, Baseler M, Wesley R, Gill VJ, Fauci AS, Lane HC. CD4+ counts as predictors of opportunistic pneumonias in Human Immunodeficiency Virus (HIV) infection. Ann Intern Med 111: 223-231, 1989.
8. Kwon-Chung KJ, Polacheck I, Bennett JE. Improved diagnostic medium for separation of Cryptococcosis neoformans var. neoformans (Serotype A and D) and Cryptococcus neoformans var. gatti (Serotype B and C). J Clin Microbiol 15: 535-537, 1982.
9. Turner BJ, Ball JK. Variations in inpatient mortality for AIDS in a national sample of hospitals. J Acquired Immune Defic Syndr 5: 978-987, 1992.
10. Clark RA, Greer D, Atkinson W, Valainis GT, Hyslop N. Spectrum of Cryptococcus neoformans infections in 68 patients with Human Immunodeficiency Virus. Rev Infect Dis 12: 768-777, 1990.
11. White M, Cirrincione C, Blevins A, Armstrong D. Cryptococcal meningitis: Outcome in patients with AIDS and patients with neoplastic diseases. J Infect Dis 165: 960-963, 1992.
12. Hoffmann S, Stenderup J, Mathiesen LR. Low yield of screening for cryptococcal antigen by latex agglutination assay on serum and cerebrospinal fluid from Danish patients with AIDS or ARC. Scand J Infect Dis 23: 697-702, 1991.
13. Stenderup J, Flensted K, Jorgensen C, Sorensen AH, Hansen NCG, Siersted HC. Forekomst af gærsvampen Cryptococcus neoformans i duegodning. Ugeskr Læger 151: 2974-2975, 1989.
14. Armstrong D. Treatment of opportunistic fungal infections. Clin Infect Dis 16: 1-9, 1993.
15. + T cells in the protective inflammatory response to a pulmonary cyptococcal infection. J Leukocyte Biol 55: 35-42, 1994.
16. Levitz SM, Dupont MP, Smail EH. Direct activity of human T lymphocytes and natural killer cells against Cryptococcus neoformans. Infect Immun 62: 194-202, 1994.
17. Lovchik JA, Lipscomp MF. Role of C5 and neutrophils in the pulmonary clearance of circulation Cryptococcus neoformans. Am J Resp Cell Molec Biol 9: 617-627, 1993.
18. Wagner RP, Levitz SM, Tabuni A, Kornfeld H. HIV-envelope protein (GP120) inhibits the activity of human bronchoalveolar macrophages against Cyptococcus neoformans. Am Rev Resp Dis 146: 1434-1438, 1992.